17909199Herbst RS, O'Neill VJ, Fehrenbacher L, Belani CP, Bonomi PD, Hart L, Melnyk O, Ramies D, Lin M, Sandler AJournal of clinical oncology : official journal of the American Society of Clinical OncologyAntineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasm Recurrence, LocalAdenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Large Cell; Disease-Free Survival; Docetaxel; Erlotinib Hydrochloride; Female; Glutamates; Guanine; Humans; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Quinazolines; Survival Rate; Taxoids; Treatment OutcomePhase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer. J Clin Oncol. 2007 Oct 20; 25(30):4743-50.J Clin Oncol2007-10-01T00:00:002007Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.Faculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD018572Concepts & Ideas531750.953678Disease-Free SurvivalD000368Living Beings46094410.373165AgedD000911Chemicals & Drugs652600.897998Antibodies, MonoclonalD005971Chemicals & Drugs7170.99132GlutamatesD016896Concepts & Ideas36434750.519249Treatment OutcomeD006147Chemicals & Drugs5110.996934GuanineD002282Disorders330.999487Adenocarcinoma, Bronchiolo-AlveolarD009367Concepts & IdeasProcedures713400.910374Neoplasm StagingD043823Chemicals & Drugs7140.990557TaxoidsPhilipBonomiPhilip Bonomi349183Bonomi, PhilipProfessor4ProfessorAuthorship 53455D018287Disorders9150.992038Carcinoma, Large CellD061067Chemicals & Drugs411130.922321Antibodies, Monoclonal, Humanized0.07969970.07969971authors10.2527has subject areaD000230Disorders581880.879374AdenocarcinomaD008875Concepts & IdeasLiving Beings48498180.3737Middle AgedD009364Disorders591840.888931Neoplasm Recurrence, LocalD000328Living Beings51785940.393502AdultD008297Physiology565156330.299056MaleD005260Physiology580162050.293542FemaleRush University, Rush Medical CollegeD002289Disorders253160.769578Carcinoma, Non-Small-Cell LungD000971Procedures542900.853608Antineoplastic Combined Chemotherapy ProtocolsInternal Medicine, Division of Hematology/Oncology/Cell Therapytrue1ProfessorProfessorD008175Disorders646250.653975Lung NeoplasmsD015996Concepts & Ideas1003480.908732Survival RateD006801Living Beings644293510.211905HumansD0000682588270.990948BevacizumabD0000684374140.993959PemetrexedD0000693479160.987813Erlotinib HydrochlorideD000369Living Beings33648440.492641Aged, 80 and overD011799Chemicals & Drugs7240.98017Quinazolines